OCI Valuation

Is OCIA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OCIA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OCIA (€10.91) is trading above our estimate of fair value (€9.59)

Significantly Below Fair Value: OCIA is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for OCIA?

Key metric: As OCIA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for OCIA. This is calculated by dividing OCIA's market cap by their current revenue.
What is OCIA's PS Ratio?
PS Ratio1.2x
SalesUS$1.95b
Market CapUS$2.44b

Price to Sales Ratio vs Peers

How does OCIA's PS Ratio compare to its peers?

The above table shows the PS ratio for OCIA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.8x
JMAT Johnson Matthey
0.2x-50.4%UK£2.2b
CRDA Croda International
3x5.1%UK£4.9b
ELM Elementis
1.3x3.4%UK£779.3m
VCT Victrex
2.6x5.8%UK£751.3m
1.2x3.6%€2.3b

Price-To-Sales vs Peers: OCIA is good value based on its Price-To-Sales Ratio (1.2x) compared to the peer average (1.8x).


Price to Sales Ratio vs Industry

How does OCIA's PS Ratio compare vs other companies in the GB Chemicals Industry?

6 CompaniesPrice / SalesEstimated GrowthMarket Cap
JMAT Johnson Matthey
0.2x-50.4%US$2.85b
SYNT Synthomer
0.1x5.0%US$335.05m
CAR Carclo
0.2x7.0%US$31.55m
HEIQ HeiQ
0.2xn/aUS$9.61m
No. of Companies6PS01.22.43.64.86+
6 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: OCIA is good value based on its Price-To-Sales Ratio (1.2x) compared to the UK Chemicals industry average (1.3x).


Price to Sales Ratio vs Fair Ratio

What is OCIA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OCIA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate OCIA's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OCIA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
€18.26
0%
46.1%€35.11€12.66n/a9
Nov ’25€10.93
€24.25
+121.8%
40.9%€35.31€12.30n/a9
Oct ’25€26.11
€31.75
+21.6%
6.0%€34.23€29.04n/a9
Sep ’25€28.90
€31.27
+8.2%
6.8%€34.19€26.18n/a12
Aug ’25n/a
€30.75
0%
11.5%€38.20€24.13n/a12
Jul ’25€23.23
€29.86
+28.6%
14.0%€37.95€21.92n/a13
Jun ’25€25.52
€29.94
+17.3%
13.8%€37.76€22.00n/a13
May ’25n/a
€30.45
0%
15.7%€38.71€22.42n/a12
Apr ’25n/a
€30.18
0%
14.9%€37.88€23.29n/a12
Mar ’25€24.20
€30.60
+26.4%
14.9%€38.29€23.54n/a12
Feb ’25n/a
€28.57
0%
17.4%€38.17€20.21n/a12
Jan ’25€26.46
€26.46
+0.02%
16.4%€37.57€19.90n/a12
Dec ’24n/a
€26.82
0%
16.5%€37.89€20.04n/a12
Nov ’24€22.04
€30.33
+37.6%
17.3%€42.08€23.92€10.9312
Oct ’24n/a
€31.16
0%
15.9%€42.10€24.85€26.1112
Sep ’24€23.34
€30.99
+32.8%
21.5%€47.21€24.19€28.9013
Aug ’24n/a
€29.83
0%
21.0%€46.70€23.03n/a12
Jul ’24€21.82
€31.92
+46.3%
21.0%€46.19€25.12€23.2312
Jun ’24€20.53
€33.26
+62.0%
19.9%€46.79€25.45€25.5212
May ’24€24.66
€35.03
+42.1%
17.1%€45.76€24.74n/a11
Apr ’24€31.17
€36.44
+16.9%
13.9%€46.74€29.80n/a11
Mar ’24€31.18
€36.98
+18.6%
11.8%€43.70€30.03€24.2010
Feb ’24€30.96
€39.37
+27.2%
8.8%€45.96€32.84n/a10
Jan ’24€33.22
€42.25
+27.2%
9.3%€48.13€33.26€26.4610
Dec ’23€40.02
€43.84
+9.6%
9.0%€49.80€34.41n/a10
Nov ’23€38.60
€44.83
+16.1%
9.5%€52.05€35.97€22.0410

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies